HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zahedi, K. Search for Related Content PubMed PubMed Citation Articles by Zahedi, K. Social Bookmarking                      What's this?

Volume 272, Number 4, Issue of January 24, 1997 pp. 2143-2148
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Characterization of the Binding of Serum Amyloid P to Laminin

(Received for publication, June 19, 1996, and in revised form, September 20, 1996)

From the Division of Nephrology, Children's Hospital Research Foundation and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229-3039

Serum amyloid P (SAP) is a member of the pentraxin family. These are evolutionarily conserved proteins made up of five noncovalently bound identical subunits that are arranged in a flat pentameric disc. Although a variety of activities have been attributed to SAP and other pentraxins, their biological functions remain unclear. In humans SAP is a constitutive serum protein that is synthesized by hepatocytes. It is encoded by a single copy gene on chromosome 1. SAP is a component of all amyloid plaques and is also a normal component of a number of basement membranes including the glomerular basement membrane. The association and distribution of SAP within the glomerular basement membrane are altered or completely disrupted in a number of nephritides (e.g. Alport's Syndrome, type II membranoproliferative glomerulonephritis, and membranous glomerulonephritis). In the present study the binding of SAP to laminin was characterized. SAP binds to human laminin and merosin as well as mouse and rat laminins. The binding of SAP to mouse laminin is saturable and calcium-dependent. The K_d of this interaction is 2.74 × 10⁷ M, with a SAP/laminin molar ratio of 1:7.1. Competition binding assays indicate that the binding of SAP to laminin is inhibited by both SAP and its analog, C-reactive protein, as well as phosphatidylethanolamine. In turbidity assays SAP enhanced the polymerization of laminin in a concentration-dependent manner. However, SAP did not alter the ability of laminin to serve as a cell adhesion substrate. Previous observations indicating that SAP binds to extracellular matrix components such as type IV collagen, proteoglycans, and fibronectin in concert with the data presented here suggest that SAP may play an important role in determining the structure of those basement membranes with which it is associated.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Herczenik and M. F. B. G. Gebbink Molecular and cellular aspects of protein misfolding and disease FASEB J, July 1, 2008; 22(7): 2115 - 2133. [Abstract] [Full Text] [PDF]

				L. Scarchilli, A. Camaioni, B. Bottazzi, V. Negri, A. Doni, L. Deban, A. Bastone, G. Salvatori, A. Mantovani, G. Siracusa, et al. PTX3 Interacts with Inter-{alpha}-trypsin Inhibitor: IMPLICATIONS FOR HYALURONAN ORGANIZATION AND CUMULUS OOPHORUS EXPANSION J. Biol. Chem., October 12, 2007; 282(41): 30161 - 30170. [Abstract] [Full Text] [PDF]

				G Zandman-Goddard, M Blank, P Langevitz, L Slutsky, M Pras, Y Levy, O Shovman, T Witte, A Doria, J Rovensky, et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity Ann Rheum Dis, December 1, 2005; 64(12): 1698 - 1702. [Abstract] [Full Text] [PDF]

				C. Mineo, A. K. Gormley, I. S. Yuhanna, S. Osborne-Lawrence, L. L. Gibson, L. Hahner, R. V. Shohet, S. Black, J. E. Salmon, D. Samols, et al. Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase Circ. Res., November 25, 2005; 97(11): 1124 - 1131. [Abstract] [Full Text] [PDF]

				T. De Celle, F. Vanrobaeys, P. Lijnen, W. M. Blankesteijn, S. Heeneman, J. Van Beeumen, B. Devreese, J. F. M Smits, and B. J. A Janssen Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion Exp Physiol, July 1, 2005; 90(4): 593 - 606. [Abstract] [Full Text] [PDF]

				D. Pilling, C. D. Buckley, M. Salmon, and R. H. Gomer Inhibition of Fibrocyte Differentiation by Serum Amyloid P J. Immunol., November 15, 2003; 171(10): 5537 - 5546. [Abstract] [Full Text] [PDF]

				T. Kimura, S. Tani, Y.-i. Matsumoto, and T. Takeda Serum Amyloid P Component Is the Shiga Toxin 2-neutralizing Factor in Human Blood J. Biol. Chem., November 2, 2001; 276(45): 41576 - 41579. [Abstract] [Full Text] [PDF]

				A. Familian, B. Zwart, H. G. Huisman, I. Rensink, D. Roem, P. L. Hordijk, L. A. Aarden, and C. E. Hack Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells J. Immunol., July 15, 2001; 167(2): 647 - 654. [Abstract] [Full Text] [PDF]

				C. Mold, H. D. Gresham, and T. W. Du Clos Serum Amyloid P Component and C-Reactive Protein Mediate Phagocytosis Through Murine Fc{{gamma}}Rs J. Immunol., January 15, 2001; 166(2): 1200 - 1205. [Abstract] [Full Text] [PDF]